Dwindling donor funding in Burundi leads to national shortage of ARVs

"Burundian NGOs say at least 20 people have died" as a result of a "months-long shortage" of antiretroviral drugs (ARVs), although "Ministry of Health officials could not be reached to confirm the number of people affected," PlusNews reports. "More than 60,000 Burundians need HIV treatment, but only about 25,000 have access to ARVs," according to the news agency, which adds, "The shortage has been blamed on dwindling donor funds and a disorganized health ministry."

"At the end of June 2011, World Bank funding -- more than US$50 million over a nine-year period -- for Burundi's AIDS response ended and has not been renewed. Together with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Bank had been one of Burundi's largest HIV donors," the news agency writes. "According to Celine Kanyonge, who heads the country's prevention of mother-to-child HIV transmission program (PMTCT), funding from the Clinton HIV/AIDS Initiative, which supported pediatric ARVs, has also ended. ... And despite the Global Fund approving some $35 million to fight HIV in Burundi under its eighth round of grants, organizations caring for HIV-positive people have still not signed agreements with the National Council for HIV/AIDS Control, CNLS, to access the cash," PlusNews reports (9/5).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Affordability and supply remain critical to the success of long-lasting HIV drug